By The Pusleline News Desk
The withdrawal of several batches of cardiac stents, angiographic catheters and colostomy bags from government hospitals has sparked growing concerns about patient safety and the integrity of the country’s medical procurement system, prompting calls for a criminal investigation into how the devices entered the public healthcare network.
The latest developments have intensified scrutiny of procurement and regulatory processes within the health sector, with doctors’ groups arguing that the removal of defective products alone is insufficient if questions about accountability remain unanswered.
A complaint has now been lodged with the Criminal Investigation Department (CID) by the Doctors’ Trade Union Alliance for Medical and Civil Rights, seeking a comprehensive inquiry into whether substandard medical devices supplied to state hospitals may have caused harm to patients and whether proper procedures were followed before the products were approved for use.
Beyond Product Recalls
Health authorities have already ordered the withdrawal of several medical devices after reports of defects and performance issues.
Among them are multiple batches of cardiac stents, which were reportedly removed following complaints of severe side effects. More recently, the Medical Supplies Division (MSD) had instructed hospitals to withdraw a batch of angiographic catheters used during coronary angiogram procedures after clinicians reported operational difficulties that could compromise patient safety.
The MSD had also ordered the recall of several batches of colostomy appliances supplied to patients who have undergone bowel-related surgeries. According to health authorities, the products suffered from poor adhesion and could cause skin irritation, reducing their effectiveness and affecting patient comfort and quality of life.
While recalls are a standard safety measure within healthcare systems worldwide, the frequency and nature of the withdrawals have raised concerns among medical professionals about whether deeper systemic issues may exist.
Questions about oversight
Specialist Dr. Chamal Sanjeewa has argued that attention must now shift from the defective products themselves to the decision-making processes that allowed them to be purchased, registered and distributed.
Doctors are calling for investigators to establish whether patients experienced complications as a result of the equipment, whether warning signs were missed during evaluation stages, and whether any failures had occurred within procurement, quality assurance or regulatory oversight mechanisms.
The case places renewed focus on the role of institutions responsible for evaluating and approving medical devices before they are introduced into clinical practice.
In Sri Lanka, medical devices supplied to government hospitals are subject to assessment by technical committees and regulatory authorities before procurement decisions are made. Critics argue that the recent recalls warrant a review of whether existing safeguards are functioning effectively.
Frontline concerns
The recall of the angiographic catheter has attracted particular attention because the device is used in procedures involving the heart’s blood vessels.
According to reports submitted by clinicians, the affected catheter had demonstrated poor torque control, was difficult to manoeuvre and presented challenges in engaging coronary arteries accurately during procedures. Medical professionals warned that such issues could potentially increase procedural risks and affect treatment outcomes.
Similarly, concerns regarding the withdrawn colostomy appliances extend beyond product quality to patient wellbeing. For individuals living with a colostomy following major surgery, reliable medical devices are essential for maintaining dignity, mobility and quality of life.
Healthcare workers note that equipment failures can create additional physical and emotional burdens for patients already coping with serious medical conditions.
Accountability and public confidence
The controversy comes at a sensitive time for Sri Lanka’s public health sector, which continues to face resource constraints while serving millions of patients through the state healthcare system.
Public confidence in hospitals depends heavily on trust that medicines, devices and treatments provided through government institutions meet accepted safety and quality standards.
Medical professionals stress that transparency will be critical as investigations move forward. Establishing whether the recalls resulted from isolated manufacturing defects or broader procurement shortcomings could help reassure both patients and healthcare workers.
For now, hospitals have been instructed to immediately remove the affected products from use and follow established recall procedures. However, the broader questions remain unresolved.
As the CID considers calls for an investigation, the focus is shifting from defective devices to the systems designed to prevent them from reaching patients in the first place. The outcome could have significant implications not only for accountability but also for future reforms in medical procurement and regulatory oversight within Sri Lanka’s healthcare sector.
Leave a comment